newsfilter
← Latest News
GlobeNewswire·

Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases,